The results of two animal studies show that the drug ABthrax improves survival rates in by up to 64 percent when administered after animals were symptomatic for anthrax disease as a result of inhalation exposure to massively lethal doses of anthrax spores, according to Human Genome Sciences, Inc. [HGSI], the developer of ABthrax. HGS says the results demonstrated a survival benefit in two animal species, which meets the requirement for establishing efficacy of new drugs used to counter bio-terrorism. "These…
Recommended
Northrop Grumman Bringing Mission Systems To Future Hermeus High-Mach Aircraft
Trending
Congress Updates
Trump Urges Senate To Move ‘Immediately’ On $350 Billion Defense Reconciliation Bill In Lame Duck
President Trump on Thursday urged Senate leadership to move “IMMEDIATELY” on a reconciliation bill that would include $350 billion for defense. The call arrives as Republicans navigate a lame duck […]
House Republicans Block Measure To Impeach Hegseth
House Republicans on Tuesday evening voted to block an attempt to impeach Defense Secretary Pete Hegseth. In a 211-204 vote, the House moved to refer Rep. Thomas Massie’s (R-Ky.) articles […]
Top House Defense Appropriator Calvert Officially Wins Reelection Bid
Rep. Ken Calvert (R-Calif.), House Republicans’ top defense appropriator, has officially won his reelection bid. Calvert was running for a redistricted seat against fellow House Republican Rep. Young Kim (R-Calif.), […]
No Path To Defense Reconciliation, Including GOP’s $350 Billion, Coons Says
Top Senate Democrats threw cold water on any GOP plans for a $350 billion fiscal 2027 reconciliation bill, or any defense reconciliation bill, before a new Congress is sworn in […]
Job Feed
-
Early Career Computer Scientist
Satellite Ground Software Modernization (Java), Onsite - Sandia National Laboratories - Albuquerque, NM -
Supervisory Physical Scientist
USA Jobs - Silver Spring, MD -
API Developer/Programmer
SURVICE Engineering Company - Aberdeen Proving Ground, -
Policy Advisor
Arnold & Porter - , DC